Gene: SFMBT2
Official Full Name: Scm like with four mbt domains 2provided by HGNC
Gene Summary: Enables histone binding activity. Involved in negative regulation of gene expression. Located in aggresome; cytosol; and nuclear speck. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14184 | SFMBT2 Knockout cell line (HeLa) | Human | SFMBT2 | 1:3~1:6 | Negative | Online Inquiry |
KO14185 | SFMBT2 Knockout cell line (HEK293) | Human | SFMBT2 | 1:3~1:6 | Negative | Online Inquiry |
KO14186 | SFMBT2 Knockout cell line (A549) | Human | SFMBT2 | 1:3~1:4 | Negative | Online Inquiry |
SFMBT2 Gene Knockout Cell Lines are genetically modified cellular systems designed for the precise study of the SFMBT2 gene function by eliminating its expression. These cell lines utilize advanced CRISPR-Cas9 technology, which facilitates specific, efficient, and targeted gene editing to generate knockout models that are invaluable for functional genomics research. By disrupting the SFMBT2 gene, researchers can investigate its role in various biological processes, including cellular proliferation, differentiation, and response to external stimuli, providing crucial insights into its contribution to health and disease.
The key function of these knockout cell lines lies in their ability to allow scientists to evaluate the phenotypic consequences of the SFMBT2 gene absence. By analyzing changes in behavior, signaling pathways, and gene expression profiles, researchers can gain a deeper understanding of the gene's biological significance and potential implications in disorders where SFMBT2 may play a critical role. The application of SFMBT2 knockout models extends beyond basic science into clinical research, particularly in understanding cancer biology and developmental disorders.
What sets SFMBT2 Gene Knockout Cell Lines apart from conventional models is the specificity and precision of the gene-editing mechanism provided by CRISPR-Cas9 technology, which minimizes off-target effects commonly associated with older methods. Additionally, these cell lines are validated for consistency and reproducibility, ensuring that data generated from experiments will be reliable and translatable.
For researchers and clinicians seeking to explore gene function and its therapeutic potential, SFMBT2 Gene Knockout Cell Lines represent an essential resource. They not only facilitate innovative research into gene therapy but also illuminate new therapeutic targets that could lead to improved treatment strategies. Our company specializes in providing high-quality biological products designed for efficiency and efficacy, ensuring that you have the best tools at your disposal to advance your research and clinical endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.